In this episode of Disruption Interruption, Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms to discuss revolutionizing respiratory diagnostics. CircoIn this episode of Disruption Interruption, Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms to discuss revolutionizing respiratory diagnostics. Circo

Disrupting Chronic Cough: Julian Circo Brings AI to the World’s Oldest Symptom

2026/02/20 04:30
6 min read

In this episode of Disruption Interruption, Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms to discuss revolutionizing respiratory diagnostics. Circo explains how Hyfe uses AI to turn coughing into an objective biomarker, offering hope for chronic cough sufferers through digital therapeutics.

TAMPA BAY, Fla., Feb. 19, 2026 /PRNewswire/ — While a cough is one of the most common medical complaints, accounting for as many as 30 million clinical visits per year, it remains one of the least understood symptoms in modern medicine. Doctors have historically relied on subjective patient recall rather than hard data, leading to stalled research and failed drug trials. Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms on the Disruption Interruption podcast to discuss how his company is solving this century-old problem by using acoustic AI to turn sound into science.

“We are building the step counter for cough,” says Circo. “Just the way that you measure your steps or your heart rate… we do that for cough. It is a key indicator to other major aspects of health.”

The Mystery of the Common Cough

Despite the prevalence of coughing, the medical community lacks a standardized baseline for what constitutes a “healthy” amount of coughing. Without objective measurement tools, diagnoses rely heavily on guesswork, and pharmaceutical advancements have struggled to gain traction. This lack of data has left millions of chronic cough sufferers without effective treatment options.

“Science could not answer the simple question of ‘what is a normal amount of coughing for a healthy person?'” explains Circo. “If you go to the top three hospitals and ask the best pulmonologist in each of them, their answer probably will differ quite significantly from each other. They don’t know what the regular amount of coughing is.”

Collecting the necessary data to train AI models is notoriously difficult due to background noise and environmental variables. “If I scrape sounds from YouTube, they may sound like coughs to my ear, but to a machine, they contain noise that I do not see,” Circo notes. “If you build an AI on those sorts of sounds, it’s going to act really funny because it will interpret noise as signal.”

Turning Sound into Biomarkers

Hyfe overcame the data shortage by launching a consumer app during the pandemic and collecting over 700 million samples to build the world’s largest cough dataset. This massive influx of real-world data allowed them to distinguish coughs from background noise, creating a frequency chart that functions much like an electrocardiogram (ECG) for respiratory health.

“We look at cough as a point in a frequency chart,” illustrates Circo. “It’s like an ECG basically. The heartbeat is one thing, but the relative time between heartbeats and the frequency of heartbeats over time becomes very, very insightful.”

Beyond diagnostics, Hyfe is pioneering a digital therapeutic for chronic coughers, a group that includes one in ten Americans. By digitizing behavioral cough suppression therapy, they offer real-time feedback to patients.

“We tell the patient exactly when to do which exercise based on actual objective cough frequency, and then we see immediately if it worked or not,” says Circo. “We already have 40% efficacy on this digital therapy.”

Links

Disrupting Diagnostics: How AI is Turning Your Cough into a Biomarker with Julian Circo

https://omny.fm/shows/disruption-interruption/disrupting-diagnostics-how-ai-is-turning-your-cough-into-a-biomarker-with-julian-circo

LinkedIn: https://www.linkedin.com/in/icirco/
Company Website: https://www.hyfe.com/

Disruption Interruption is the podcast where you will hear from today’s biggest Industry Disruptors. Learn what motivated them to bring about innovation and how they overcame opposition to adoption.

Disruption Interruption can be listened to in Apple’s App Store and Spotify.

About Disruption InterruptionTM
Disruption is happening on an unprecedented scale, impacting all manner of industries— MedTech, Finance, IT, eCommerce, shipping, logistics, and more—and COVID has moved their timelines up a full decade or more. But WHO are these disruptors and when did they say, “THAT’S IT! I’VE HAD IT!”? Time to Disrupt and Interrupt with host Karla Jo “KJ” Helms, veteran communications disruptor. KJ interviews badasses who are disrupting their industries and altering economic networks that have become antiquated with an establishment resistant to progress. She delves into uncovering secrets from industry rebels and quiet revolutionaries that uncover common traits—and not-so-common—that are changing our economic markets… and lives. Visit the world’s key pioneers that persist to success, despite arrows in their backs at www.disruption-interruption.com.

About Julian Circo

Julian Circo is a pioneering entrepreneur operating at the intersection of artificial intelligence, respiratory health, and global impact. As the Co-Founder of Hyfe, he is transforming coughing, one of medicine’s most common yet least understood symptoms, into an objective, quantifiable biomarker through acoustic AI and the world’s largest cough dataset, containing over 700 million samples.

Before building Hyfe into a global leader in precision cough care, Julian founded and scaled multiple impact ventures across healthcare and fintech. His career is uniquely shaped by decades of frontline leadership in some of the world’s most challenging environments, including humanitarian missions and senior operational roles supporting global organizations in Somalia, Mozambique, East Timor, and the Democratic Republic of Congo.

Today, Julian is advancing the emerging field of acoustic epidemiology, using bodily sounds such as coughs and wheezing to improve disease prediction, diagnostics, and digital therapeutics. Beyond Hyfe, he remains actively involved with several mission-driven ventures as an advisor, investor, board member, and advocate for innovation that combines profitability with measurable social good.

About Karla Jo Helms
Karla Jo Helms is the Chief Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™. Karla Jo learned firsthand how unforgiving business can be when millions of dollars are on the line — and how the control of public opinion often determines whether one company is happily chosen, or another is brutally rejected. Being an alumnus of crisis management, Karla Jo has worked with litigation attorneys, private investigators, and the media to help restore companies of goodwill into the good graces of public opinion — Karla Jo operates on the ethic of getting it right the first time, not relying on second chances and doing what it takes to excel. Helms speaks globally on public relations, how the PR industry itself has lost its way, and how, in the right hands, corporations can harness the power of Anti-PR to drive markets and impact market perception.

References

Sharma, S., Hashmi, M. F., & Alhajjaj, M. S. (2023, August 8). Cough. PubMed; StatPearls Publishing. ncbi.nlm.nih.gov/books/NBK493221/

Media Inquiries:
Karla Jo Helms
JOTO PR™ 
727-777-4629

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/disrupting-chronic-cough-julian-circo-brings-ai-to-the-worlds-oldest-symptom-302693008.html

SOURCE Disruption Interruption

Market Opportunity
Marina Protocol Logo
Marina Protocol Price(BAY)
$0.03826
$0.03826$0.03826
-0.18%
USD
Marina Protocol (BAY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

The US SEC on Wednesday approved new listing rules for major exchanges, paving the way for a surge of crypto spot exchange-traded funds. On Wednesday, the regulator voted to let Nasdaq, Cboe BZX and NYSE Arca adopt generic listing standards for commodity-based trust shares. The decision clears the final hurdle for asset managers seeking to launch spot ETFs tied to cryptocurrencies beyond Bitcoin and Ether. In July, the SEC outlined how exchanges could bring new products to market under the framework. Asset managers and exchanges must now meet specific criteria, but will no longer need to undergo drawn-out case-by-case reviews. Solana And XRP Funds Seen to Be First In Line Under the new system, the time from filing to launch can shrink to as little as 75 days, compared with up to 240 days or more under the old rules. “This is the crypto ETP framework we’ve been waiting for,” Bloomberg research analyst James Seyffart said on X, predicting a wave of new products in the coming months. The first filings likely to benefit are those tracking Solana and XRP, both of which have sat in limbo for more than a year. SEC Chair Paul Atkins said the approval reflects a commitment to reduce barriers and foster innovation while maintaining investor protections. The move comes under the administration of President Donald Trump, which has signaled strong support for digital assets after years of hesitation during the Biden era. New Standards Replace Lengthy Reviews And Repeated Denials Until now, the commission reviewed each application separately, requiring one filing from the exchange and another from the asset manager. This dual process often dragged on for months and led to repeated denials. Even Bitcoin spot ETFs, finally approved in Jan. 2024, arrived only after years of resistance and a legal battle with Grayscale. According to Bloomberg ETF analyst Eric Balchunas, the streamlined rules could apply to any cryptocurrency with at least six months of futures trading on the Coinbase Derivatives Exchange. That means more than a dozen tokens may now qualify for listing, potentially unleashing a new wave of altcoin ETFs. SEC Clears Grayscale Large Cap Fund Tracking CoinDesk 5 Index The SEC also approved the Grayscale Digital Large Cap Fund, which tracks the CoinDesk 5 Index, including Bitcoin, Ether, XRP, Solana and Cardano. Alongside this, it cleared the launch of options linked to the Cboe Bitcoin US ETF Index and its mini contract, broadening the set of crypto-linked derivatives on regulated US markets. Analysts say the shift shows how far US policy has moved. Where once regulators resisted digital assets, the latest changes show a growing willingness to bring them into the mainstream financial system under established safeguards
Share
CryptoNews2025/09/18 12:40
XRP Price Prediction February 2026: Senator Warren Warns Fed as Pepeto’s 100x Presale Steals the Spotlight From Ripple

XRP Price Prediction February 2026: Senator Warren Warns Fed as Pepeto’s 100x Presale Steals the Spotlight From Ripple

Senator Elizabeth Warren reportedly sent a letter to Fed Chair Jerome Powell and Treasury Secretary Scott Bessent demanding they not […] The post XRP Price Prediction
Share
Coindoo2026/02/22 05:55
Trump raises global tariff rate to 15%, but crypto markets are unfazed

Trump raises global tariff rate to 15%, but crypto markets are unfazed

US President Donald Trump is now using alternative legal routes to levy tariffs, but critics say his authority to impose them is still limited.United States President
Share
Coinstats2026/02/22 05:45